Metraipolis › archive › dc_ec555d67b98f

Cost-effectiveness of pre-emptive pharmacogenetic testing: An umbrella review — Europe PMC PMID:42302010

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42302010
DOI: 10.1371/journal.pone.0338277
License (as archived): solo-consultazione
Archived: 2026-10-31T10:46:17.313Z
SHA-256 of the archived text: 8b74db7173335b951939e767bb5bb546dd4b61972249c278b69af9a8f1fb715d
Stable URL of this page: https://metraipolis.com/documento/dc_ec555d67b98f

How to cite

Cost-effectiveness of pre-emptive pharmacogenetic testing: An umbrella review — Europe PMC PMID:42302010 — Europe PMC (en), https://europepmc.org/article/MED/42302010 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ec555d67b98f (Metraipolis archive dc_ec555d67b98f, sha256 8b74db7173335b951939e767bb5bb546dd4b61972249c278b69af9a8f1fb715d)

BibTeX

@misc{dcec555d67b98f,
  title = {Cost-effectiveness of pre-emptive pharmacogenetic testing: An umbrella review — Europe PMC PMID:42302010},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42302010},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ec555d67b98f; sha256 8b74db7173335b951939e767bb5bb546dd4b61972249c278b69af9a8f1fb715d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42302010. Agents can read the archived copy with the MCP tool read_document.